PBI-6DNJ
PBI-6DNJ is a potent, orally bioavailable multivalent glycosidase inhibitor with a Ki of 0.14 μM against murine α-glucosidase. It demonstrates significant hypoglycemic effects in vivo, making it a valuable research tool for studying type 2 diabetes mechanisms and potential therapeutic strategies.
Product Specifications
Field of Research
Metabolism Research
Molecular Formula
C120H146N26O36
Molecular Weight
2528.6
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
38789116 3x 1.0 µg
Reep5 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details 
